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Criteria for interpretation of antibiotic sensitivity tests of stains of 
N. gonorrhoeae
Drug Concentrationof disk
Zone size (Diameters in mm)
Resistant Moderately sensitive Sensitive
Penicillin 10 I.U. ≤ 26 27-46 ≥ 47
Ciprofloxacin 5 mcg ≤ 27 28-40 ≥ 41
Ceftriaxone 30 mcg - - ≥ 35
Cefixime 5 mcg - - ≥ 31
Spectinomyci
n 100 mcg ≤ 14 15-17 ≥ 18
Azithromycin 15 mcg ≤ 13 14-17 ≥ 18
INTRODUCTION
         Sexually transmitted diseases are prevalent through out the world. 
About 340 million new cases reported every year.1 Incidence of new STD 
cases per year in India is about 40 million or 5% of population.2 Globally 
around  39.4  million  person  are  living  with  HIV/AIDS,  and India  has 
5.13million HIV infections.1  Sexually transmitted diseases (STD) play a 
major  role  in  the  transmission  of  HIV infection.  Thus  prevention  and 
control of STD is one of the major strategies for the control of HIV. 
STD can be grouped as ulcerative and non-ulcerative. The risk of 
acquiring HIV infection in ulcerative STD is 5 to 7 times and in non 
ulcerative STD to 3 to 5 times more than that in persons without any 
sexually transmitted infections.3 Since the prevalence of non-ulcerative 
STD  is  higher  than  ulcerative  STD,  it  represents  the  population  at 
attributable risk in the transmission of HIV.4    
One of the main non- ulcerative STD is Gonorrhoea. The relative 
incidence of  gonococcal infections is about 10 to 13% of total sexually 
transmitted infections in STD clinics.5,6 Common symptoms are urethritis 
in male and cervicitis is female.  HIV positive men with urethritis  had 
HIV concentrations in the semen more than those in seropositive men 
without urethritis. After treatment of urethritis the concentrations of HIV 
in semen decreased significantly.7  Causative organism for gonorrhoea is 
Neisseria gonorrhoeae. Man being the only natural host. N. gonorrhoeae 
usually  produces  purulent  exudates,  but  signs  and  symptoms  of  the 
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disease  may  be  absent  especially  in  women  or  indistinguishable  from 
those  of  Chlamydial  infection.  Therefore,  laboratory  procedures  are 
needed for the diagnosis.8 
In  recent  years,  there  has  been  an  alarming  increase  in 
ciprofloxacin  and  penicillin-resistant  N.  gonorrhoeae  in  India.9 
Establishing appropriate treatment strategies is further complicated by the 
rapidly changing resistance patterns. Hence monitoring of drug resistance 
patterns at regular intervals, is essential.         
Before the emergence of penicillinase producing N. gonorrhoea in 
1976,  increased  doses  of  penicillin  remained  the  drug  of  choice  for 
treating uncomplicated urogenital infections through out the world.10  But 
now high doses of penicillin is ineffective in PPNG strains. Because of 
renewed  interest  in  developing  alternative  gonococcal  therapies,  a 
number of compounds with proven efficacy against both PPNG and non 
PPNG  have  been  described.  Isolates  from  developing  countries  have 
shown decreased susceptibility to many of these, presumably as a result 
of intense antibiotic pressure favoring the selection of resistance strains.  
In  the  management  of  gonorrhoea  it  is  not  practicable  to  delay 
treatment  until  the  results  of  susceptibility  tests  are  known.  Hence 
alternative  approach  is  to  know  the  periodic  patterns  of  gonococcal 
sensitivity  for  antibiotics.  Culture  is  essential  for  surveillance  for 
antimicrobial  susceptibility  which  provides  guidance  for  appropriate 
treatment depending on the strains prevalent in the region.          
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Other  sexually  transmitted  infections  like  HIV,  Syphilis, 
Trichomoniasis are common with gonorrhoea.11 Presence of gonococcal 
infection  aids  in  acquiring  HIV  infection.  So  proper  diagnosis  and 
treatment  with  sensitive  antibiotics  is  necessary  to  prevent   the 
complications of gonorrhoea and the spread of HIV.
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REVIEW OF LITERATURE
Historical Perspectives         
Gonorrhoea  is  one  of  the  oldest  known  diseases  of  humans. 
Thedisease was described in the old Testament in chapter Leviticus, 15:2. 
Hippocrates (460-350 BC) called acute Gonorrhoea as "Strangury" and 
said   resulted  from the  "Pleasures  of  Venus".12  Galen  (130-200 AD)  
a  Greek  hysician  coined  the  term  "gonorrhoea"  (gono=seed;  
rrhoea= flow).13  In ancient medical treatise, the condition "dysuria" was 
dealt exhaustively under the chapter "Diseases of urinary passages" by 
Sushrutha (500 AD).14               
Ambroise Pare (sixth century) and John Hunter  (eighth century) 
considered Syphilis and Gonorrhoea to be different manifestations of a 
single disease. Distinction between the two was first clearly achieved by 
Phillippe Ricord in 1831.15  The etiologic  agent  was identified  in 1879 
byAlbert  Ludwig  Neisser  from  Poland  the  stained  smears  of 
inflammatory urethral exudates.16 Leistikow and Leoffler in 188217 and 
Bumm  in  1885  grew the  organism in  culture  media  of  blood  serum, 
gelatin  and  coagulated  human  serum  respectively.  Hans  Gram 
demonstrated  the  organism  by  grams  staining  in  1884.18 Gonococcal 
complement fixation test and Oxidase test were introduced by Muller and 
Oppenheim in  1906,  and  Gordon  and  Mcleod  in  1988  respectively.19 
Diagnostic procedure further augmented in 20th century with development 
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of  fluorescent  antibody  technique,  serological  tests  for  gonococcal 
antibodies and DNA amplification by LCR.20-21 Variance in virulence of 
Gonococcus with different  colonial Morphology  was demonstrated by 
Kelogg and co workers in 1963.22
MORPHOLOGY         
Gonorrhoea is caused by Neisseria gonorrhoeae belonging to the 
Family, Neisseriaceae and genus Neisseria. Gonococci are gram negative, 
non-motile,  non-sporulating  cocci  measuring  0.8  x  0.6  mm  in  size, 
typically arranged in pairs (diplococci) with sides concave, reniform or 
pear-shaped.  They grow poorly  on ordinary media  requiring serum or 
blood. Catalase and Oxidase positive, indole negative and reduce nitrite 
but not nitrate.          
In  smears  from urethral  discharge  gonococci  are  predominantly 
within the polymorphs but in cultures they appear as oval or spherical 
cocci without the typical diplococcal arrangement.  The organism lacks a 
true  outer  polysaccharide  capsule.  Instead,  it  produces  a  surface 
polyphate  or  'pseudocapsule'  which  is  responsible  for  the  hydrophilic 
negatively charged  cell surface of the organism.
ULTRASTRUCTURE AND ANTIGENIC PROPERTIES          
Inner to the cell wall is the outer cell membrane made up of Lipo-
oligosaccharide (LOS). Six distinct entities of LOS varying in size from 3 
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to  7  kDa  are  recognized.  LOS  act  as  endotoxins.  Exotoxins  are  not 
elaborated by gonococci. LOS is a target for bactericidal antibodies.23-24 
PILI         
These  are  protein  polymers  that  project  from  the  surface  of 
bacterial  cell  and  mediate  attachment.  They  promote  virulence  by 
preventing  neutrophilic  phagocytosis  and involved in  the  exchange  of 
genetic material.25 
PORIN          
Extends  through  the  gonococcal  cell  membrane  through  which 
some nutrients enter the cell. Each strain of gonococcus expresses only 
one type of Por but  different  strains are antigenically  different.  It  is a 
target for bactericidal opsonic antibodies.26-27           
Opa (protein II) functions in adhesion of gonococci within colonies 
and in attachment  of  gonococci  to host  cell.  A strain can possess 1-3 
types of Opa. Each strain has 10 or more genes for different opas. Opa is 
responsible for opaque colonies.          
Rmp (Protein III) is a reduction modifiable protein. It associates 
with Por in the formation of pores in the cell surface.          
Iron- or oxygen-repressible proteins are expressed by gonococcal 
membrane  under  limited  growth situations,  such as  iron deficiency  or 
anaerobic environment. They perform the function of iron transport.28-29  
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Ig  A1  protease:  Gonococci  elaborate  two  genetically  and 
biochemically  distinct  variants  of  protease  called  Ig  A1  protease.  It 
recognizes both serum and secretory IgA 1 antibody and cleaves it at the 
hinge region forming Fab and Fc fragments, thus inactivating the mucosal 
immune defenses. 
Auxotypes         
Strains  of  gonococci  that  need  specific  requirements  for  certain 
nutritional growth factors are known as auxotypes. They are important for 
epidemiological studies in order to differentiate one strain from other. A 
strain unable to grow without arginine is designated as Arg- or without 
leucine  is  Leu-.  This  is  helpful  in  assessing  the  potential  virulence, 
invasiveness,  antimicrobial  susceptibility  and  genetic  constitution  of 
various gonococcal strains.30                     
Arg-Hyx-Ura-  (AHU)  strains  are  recovered  from  patients  with 
disseminated gonococcal infection, and are frequently resistant to normal 
bactericidal  action  of  human  serum.  Further  they  are  associated  with 
asymptomatic  urethral  infection  in  men,  are  highly  susceptible  to 
penicillins, and form atypical colonies on culture requiring 72 hours or 
more of incubation time for growth.31  Gonococci requiring none of the 
growth factors are termed prototrophic or the wild type.
7
GENETIC CHARACTERISTICS
Transformation
The  pilated  gonococci  are  capable  of  undergoing  chromosomal 
DNA transformation by exogenous DNA at all stages of their life cycle. 
This property may be responsible for transfer of genes between different 
strains in chromosomally mediated antibiotic resistant genes.   
Conjugation
Gonococci also contain conjugal plasmids that can be transferred 
from one strain to another by pili. Nine plasmids are described throughout 
the world, out of which six are involved in penicillin resistance.   
PATHOGENESIS          
Gonococci has a predilection for columnar and cuboidal epithelium 
of genitourinary tract, eye, rectum and throat producing acute suppuration 
that may lead to tissue invasion followed by chronic inflammation and 
fibrosis.  Cornified or  stratified squamous and transitional  epithelia  are 
resistant to this organism.           
The initial event of infection is adherence of gonococci to mucosal 
cells in a process mediated by pili, opa and other surface proteins. It is 
pinocytosed by epithelial cells to the sub epithelial space and is attached 
to  nonciliated  epithelial  cells.  Gonococcal  LOS  (endotoxin)  impairs 
ciliary  motility  and  destroys  surrounding  ciliary  cells.  This  promotes 
further  attachment  of  additional  organisms.  Progressive  mucosal  cell 
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damage  and  sub  mucosal  invasion  are  accompanied  by  vigorous 
polymorphonuclear  leukocyte  response,  submucosal  microabscess 
formation and exudation of purulent material into the lumen of infected 
organ.           
If untreated polymorphonuclear leukocytes are gradually replaced 
by  mononuclear  cells  and  abnormal  round  cell  infiltration  has  been 
reported to persist for several weeks after which gonococci can no longer 
be isolated.32
CLINICAL MANIFESTATIONS          
Incubation period varies from 1 to 14 days with an average of 2-5 
days. 
Acute Gonorrhoea in men 
It  presents  as  acute  anterior  urethritis  which is  characterized by 
symptoms of dysuria and copious urethral  discharge.  The discharge is 
profuse, yellow to yellowish green purulent one. The lips of the external 
urinary  meatus  are  edematous  and  there  is  associated  perimeatal 
erythema. Tender inguinal lymphadenopathy may be present. One quarter 
of  patients  develop  only  scanty  or  minimally  purulent  exudates 
indistinguishable from non- gonococcal urethritis.           
If prompt treatment is not initiated, posterior urethritis may ensue 
in  10-14  days,  which  presents  as  frequency  of  micturition,  urgency, 
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occasional strangury and rarely tenesmus. Erection may be painful. The 
extend of involvement can be assessed by performing two glass test.33  In 
this test  the patient is  asked to void urine in 2 glasses after overnight 
urine holding. In anterior urethritis, only the first urine specimen is hazy 
or  cloudy and the  specimen  in  the  second glass  is  clear.  Presence  of 
haziness or threads in the second glass suggests  posterior urethritis.  A 
three  glass  test  is  also  performed  for  greater  accuracy,  in  which  the 
anterior urethra is irrigated with a colorless antiseptic solution (such as 
1: 8000 oxycyanide of mercury) until the washings in the first glass are 
clear. The patient then voids urine in two other glasses. Presence of haze 
in the first glass suggests posterior urethritis and in the second depicts 
involvement of the bladder.        
Acute  gonococcal  infection  can  also  produce  acute  tysonitis, 
phimosis,  paraphimosis,  littritis,  inflammation  of  periurethral  and 
paraurethral glands, balanitis, cowperitis, prostatitis, seminal vesiculitis, 
epididymitis, trigonitis, pustular lesions over penile skin associated with 
shallow ulceration around the frenulum.
Complicated Gonorrhoea in Men
In  the  absence  of  treatment,  spontaneous  resolution  occurs  in 
majority  of  cases  after  4-6  weeks,  with  95%  of  the  cases  becoming 
asymptomatic  within  6  months.  In  rare  instances,  if  the  patient  goes 
untreated or proves refractory to treatment, serious sequelae may ensue. 
They are  urethral  strictures  fistulae  leading to  watering-can perineum, 
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chronic littritis, cowperitis, prostatitis, seminal vesiculitis or epididymitis. 
Penile  lymphangitis  associated  with  regional  lymphadenitis  and penile 
oedema (bull headed clap) are the other complications.
Acute Gonorrhoea in Women 
Uncomplicated  gonorrhoea  in  women  remain  asymptomatic  in 
about 50% of cases that may act as a reservoir of infection. The primary 
site  of  infection  is  endocervical  canal.  The  organism  colonises  the 
urethra, bartholin and skene's glands and spreads to involve the cervix, 
uterus, fallopian tubes and pelvis. The vulva, vagina, bladder and upper 
urinary tract are relatively spared.      
Acute gonococcal infection in females presents as endocervicitis, 
which  is  characterized  by  purulent  vaginal  discharge,  dysuria, 
intermenstrual  uterine  bleeding  and  menorrhagia.  On  speculum 
examination,  copious  pus  emanating  from  the  external  os  can  be 
visualized. There is severe erythema and oedema of the zone of ectopy 
and associated mucosal bleeding induced by swabbing the endocervix.34 
Cervical erosions may also be present. Purulent urethral discharge may be 
expressed by massaging on the urethra from above downwards through 
the  anterior  vaginal  wall.  Endocervicitis  results  in  blockade  of  the 
cervical  glands and formation of retention cysts or Nabothian follicles 
that protrude into the vaginal portion of cervix.         
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Acute  gonococcal  vulvitis  is  rare  and  may  present  as  edema. 
Erythema and tenderness of the labia. Gonococcal cystitis and trigonitis is 
also extremely uncommon.
Complicated Gonorrhoea in Women
Pelvic  Inflammatory  Disease  (PID)  is  the  most  common  local 
complication accounting for 10 to 20% of cases with acute gonococcal 
infection.35 The incidence of gonococcal PID is highest during the early 
proliferative phase of the menstrual cycle. This is as a result of cyclical 
changes  in  both  the complement  function  and antibacterial  activity  of 
serum secondary to changes in sex harmone levels.36          
Acute  salpingitis,  tubo-ovarian  abscess,  pelvic  abscess,  pelvic 
peritonitis,  chronic  urethritis,  skenitis,  bartholinitis,  proctitis,  frozen 
pelvis, tubal infertility, ectopic pregnancies and chronic pelvic pain are 
the other complications of gonorrhoea in women.
Anorectal Gonorrhoea
Gonococcal proctitis in males usually results from anal coitus in 
passive homosexuals and rectum is a frequent site of infection in 40% of 
homosexual men.37  In women, the rectal mucosa is infected in 35% to 
50%  of  cases  with  gonococcal  cervicitis  consequent  upon  perineal 
contamination  with  infected  cervical  secretions.  Symptoms  may  be 
pruritus,  mucopurulent  discharge,  rectal  bleeding,  tenesmus,  and 
constipation.
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Pharyngeal gonorrhoea
This has been reported in about 3-7% of heterosexual  men with 
gonorrhoea, 10-20% of infected women and 10-25% of homosexual men. 
Pharyngeal  infection alone is present  in  5% of gonococcal  cases.  The 
infection  is  transmitted  by  oro-genital  contact  and  is  more  efficiently 
acquired by fellatio than by cunnilingus.38   Symptoms are usually absent 
or mild in 90% of cases in few instances, acute pharyngitis or tonsillitis 
may  occur.  Pharyngeal  gonorrhoea  is  a  risk  factor  for  developing 
disseminated gonococcal infection.39
Gonococcal conjunctivitis 
It  is  a  rare  entity  in  adults  and  often  seen  in  patients  with 
concomitant  anogenital  gonorrhoea  as  a  consequence  of  direct 
contamination by fingers or towels. The condition may be asymptomatic 
or  mild  infection  to  severe  forms  resulting  in  corneal  ulcerations  and 
panophthalmitis.40
Disseminated gonococcal infection (DGI)
This occur from the first day to 3 months. It is due to gonococcal 
bacteremia manifested by acute arthritis, tenosynovitis and dermatitis. It 
is common in women than in men.          
Bacteremia begins from 7 to 30 days. Pregnancy and pharyngeal 
gonococcal infections are risk factors. Complement deficiency especially 
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terminal  components  C5-C8 is  found  in  13%  of  DGI.  DGI  are  AHU 
negative auzotype, serotype protein I (Por) A, resistance to human serum 
and are penicillin sensitive. But now both plasmid mediated PPNG and 
chromosomally  mediated  antibiotic  resistant  strains  have been isolated 
from these patients.41 
Arthritis
Migratory arthralgia resolve spontaneously or progress into septic 
arthritis  of  knee,  ankle,  elbow and wrist  are  involved asymmetrically. 
Upper extremity more often than the lower.
Tenosynovitis
Common in dorsum of hand, wrist, ankles, or knees.
Dermatitis
75% of DGI have tiny papule, pustules, vesicles with erythematous 
base. Centre of the lesion becomes necrotic or haemorrhagic. Erythema 
nodosum and erythema multiforme lesion may also be seen.42
Gonococcal endocarditis 
It  occurs in 1 to 3% of DGI, but  not  common and it  results  in 
progressive valvular damage with abundant skin lesion, emboli to kidney 
and  brain.  Pericarditis  with  ECG  changes,  pericardial  friction  rub, 
purulent pericardial fluid and myocarditis suggested by tachycardia and 
ST-T wave changes occurs.
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Gonococcal Perihepatitis
Fitz Hugh Curtis syndrome is due to extension of infection from 
fallopian tube by lymphangitis  or via hematogenous spread.  It  mimics 
cholecystitis.  Overwhelming  sepsis  with  Water-House  Friderichson 
syndrome or adult respiratory distress syndrome is rare.
Meningitis
Few  cases  were  reported  with  typical  presentation  of  acute 
bacterial meningitis without typical findings of DGI. In CSF Neisseria 
gonorrhoeae is indistinguishable from N. meningitidis. 
Gonorrhoea in Pregnancy
Is  associated  with  increased  risk  of  spontaneous  abortion, 
premature labor,  early rupture of fetal  membranes and perinatal  infant 
mortality. Pelvic inflammatory disease is uncommon after first trimester.
Neonatal Gonorrhoea 
A purulent to mucopurulent discharge from the eyes of an infant 
starting within 21 days of birth. Average incubation period is 1-4 days. 
The  symptoms  are  red  edematous,  painful  eyes  with  pus  oozing  out. 
Cornea may be involved. In severe cases eye may be destroyed.
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Childhood Gonococcal Vulvo-Vaginitis 
Usual  means  of  acquiring  infection  is  poor  hygiene  because  of 
contact between the child's genitalia and the contaminated hands of an 
adult with gonorrhoea causing inflammation of vulva and vagina. Sexual 
assault may need to be ruled out.
Co-infection with Chlamydia Trachomatis 
This commonly accompanies gonococcal infection in 10-20% of 
men  and  20-30% of  women.43 Patients  with  concurrent  infections  are 
either asymptomatic or have fewer symptoms as compared to cases with 
gonorrhoea alone.
LABORATORY DIAGNOSIS 
SPECIMENS AND SITES OF COLLECTION 
Acute symptomatic cases  :  Urethral swab, Endocervial, Rectal 
and
Anal swab.
Asymptomatic cases : Early morning first voided urine sample. 
Chronic cases    :  Prostatic massage.
Tysonitis, Bartholin 
abscess,  Skenitis             :  Pus
Distant infection sites : Conjuctival  swab,  Pharyngeal  swab. 
Metastatic Infection sites : Pus, CSF, Blood, Synovial fluid.
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Specimen Transport
The  specimen  is  transported  in  various  non-nutritive  Transport 
media  such  as  Amie's  or  modified  Stuart's  medium.  It  should  be 
processed within 6 hours. Stuart's transport medium is used with charcoal 
treated swabs. 
DIRECT DEMONSTRATION OF N.GONORRHOEAE
Staining Methods
Methylene  blue  stain  is  simple  stain  used  to  demonstrate 
Morphology of the intra cellular diplococci alone.          
Gram  stained  smear  reveals  gram  negative  diploccocci  within 
polymorphonuclear leukocytes. In symptomatic men sensitivity is 90%, 
Specificity is 95%.  In females with endocervical  exudates,  sensitivity 
is50%  and  specificity  is  95%.  In  PID,  the  sensitivity  is  60-70%  and 
specificity  is  from 95-100%.  Anorectal  smears  obtained from patients 
with proctitis have a sensitivity of 40-60%.
CULTURE          
Culture  is  considered  the  'gold  standard'  for  the  diagnosis  of 
gonorrhoea. It is obligatory especially in the diagnosis of oropharyngeal, 
rectal, disseminated or asymptomatic infection in both sexes. It is also 
essential  in  determining  antibiotic  sensitivity  pattern  and  treatment 
efficacy.
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Gonococci are fastidious organisms requiring enriched media for 
growth.  They  are  aerobic  and  capnophilic  (requiring  5-10%  CO2 for 
growth). Optimum growth occurs at 35-36o C. 
No growth occurs below 25o C or above 38.5o C. It requires a moist 
environment and a pH between 7.2 and 7.6.
Selective culture Media 
Thayer-  Martin  Medium:  Chocolate  agar  based  medium 
supplemented  with  growth  factors  for  fastidious  microorganisms  and 
antimicrobial vancomycin and colistin that inhibit gram +ve and gram-ve 
bacteria and nystatin to inhibit yeasts and moulds.      
Modified  Thayer  Martin  Medium:  This  contains  Thayer  Martin 
Medium+ trimethoprim for  recovery  from rectal  swabs.  Trimethoprim 
Prevents swarming of proteus. 
New  York  City  Medium-  Corn  starch  agar  based  medium 
containing  yeast  dialysate,  citrated  horse  plasma  and  lysed  horse 
erythrocytes with vancomycin, colistin, amphotericin and trimethoprim.   
Other  enriched  media  for  gonococcal  isolation  include  Chacko-
Nair  medium,  Martin  Lewis,  GC-Lect  medium,  chocolate  agar, 
haemoglobin yeast liver (HYL) medium and blood agar.         
Vancomycin  free  Selective  Medium  (VFSM)  for  vancomycin 
sensitive strains of N.gonorrhoeae.44
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              Sensitivity of culture is reported between 80% and 95%, with false 
negative results attributed to poor specimen storage, transport problems 
and inhibition of growth by the components of selective media.
GROWTH AND CULTURAL CHARACTERISTICS         
Gonococci  form small,  round, translucent,  soft,  emulsifiable  and 
convex colonies with fine granular surface and lobate crenated margins of 
1mm size. The colonical types recognizable are types T1-T4. Kelogg in 
1963  described  these  types  by  growing  them on  a  clear  medium and 
viewing with obliquely transmitted light. T1 and T2 colonies are found in 
primary  cultures  obtained  from the  clinical  material,  while  T3and  T4 
colonies appear on subcultures.         
T1 and T2 colonies are small,  lenticular and brown and possess 
pilated gonococci  (P+ and P++).  T3 and T4 colonies are  larger,  flatter, 
granular  and  non  pigmented  and  contain  non-pilated  organisms  
(P-  and P-). Jephcott et al in 1971 reported another type of colony, i.e. 
T5.45 This colony appear very shiny like T2 and as large as T3. It was 
dark brown in colour, granular with concentric rings on its surface and 
coarse, irregular margins.          
Based  on  the  expressions  of  an  outer  membrane  protein  called 
protein II (PII), the colonies may be differentiated into transparent (Tr) 
and opaque (Op) types when viewed through a light  microscope on a 
clear media in appropriate lighting.         
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Kelogg  and  his  coworkers  observed  that  after  repeated  in  vitro 
passages,  P+ "type  1"  colonies  retained  their  virulence  whereas  the  
P- "type 4" colonies lost  it.  P-colonies have decreased ability  to cause 
infection in males.
BIOCHEMICAL REACTIONS          
N. gonorrhoeae is oxidase, catalase positive. It ferments glucose, 
but not maltose, sucrose, fructose, or lactose producing acid but no gas. 
Carbohydrate  utilisation  tests  are  used  to  distinguish  between 
N.gonorrhoeae  and  N.  meningitidis.  Serum  free  media  like  cysteine- 
Trypticase agar or Muller- Hinton agar with appropriate carbohydrate and 
indicator are commonly used.         
Acidification of Carbohydrate Containing Media: are conventional 
cysteine tryptic  digest  semisolid agar-  base  (CTA) medium containing 
1%  carbohydrate  and  phenol  red  pH  indicator,  Rapid  carbohydrate 
utilization test and commercial carbohydrate utilization tests like, RIM-
N-Kit,  Neisseria-Kwik  test  kit,  Gonobio-  Test,  Bactec  test,  Minitek 
Neisseria Test and API Quad-Ferm are useful.
Definitive identification of N. gonorrhoeae         
Rapid carbohydrate utilization Test (RCUT): Most frequently used 
rapid carbohydrate utilization test are non-growth dependent and utilizes 
preformed enzymes is more sensitive and specific. They combine ease of 
performance, rapidity and reliability with low cost.      
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Presence of pre-formed enzymes elaborated during growth allows 
degradation of the carbohydrates and results in the production of acid. 
The test is performed in a non-growth dependent buffered salt solution 
with pH indicator phenol red which changes colour from red to yellow as 
acid is formed.         
A test for  β  lactamase production has been incorporated into the 
RCUT which can be detected by change in colour of phenol red from red 
to yellow,when penicillin is converted to penicillinoic acid. Ampicillin 
which is morestable and sensitive to TEM β  lactamase is used instead of 
penicillin G in the test.          
β  Lactamase Detection
Apart from ampicillin in RCUT, methods to detect  β  lactamase are 
chromogenic cephalosporin (Nitrocefin) test, paper acidometric method 
and rapid tube iodometric method and paper iodometric test.46           
β  lactamase is an extracellular enzyme produced by many strains 
of bacteria, specifically hydrolyses the amide bond in the β  lactam ring of 
penicillin analogues, rendering this antibiotic inactive. Penicillinoic acid 
is formed with a resulting colour change.          
Fluorescent Antibody staining: Blind sweep of growth after 24-48 
hrs of incubation or at 18 hours is taken. Polyclonal antibodies against the 
epitopes  on  the  major  outer  membrane  proteins  (MOMPS)  are  used. 
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Current  procedure utilise  monoclonal  mouse  antigonococcal  antibodies 
against epitopes on P.I of N.gonorrhoeae. The organism appear as apple-
green fluorescent diplococci.         
Co-agglutination
 Recent  modification  of  the  Swedish  monoclonal  system as  the 
Phadebact monoclonal GC test is antibody coated staphylococci used to 
detect  those  gonococci  no  longer  identified  by  alternative  monoclonal 
antibodies.          
Lectin Agglutination
The  binding  of  wheat  germ a  glycoprotein  to  the  B   D 1.4  N 
acetylglucosamine  of  a  carbohydrate  moiety  is  used  a  rapid  test  to 
differentiate cultured gonococci from other Neisseriae.         
Chromogenic Enzyme Substrate Tests 
Specific for gonococci only and the system must b used only on 
specimens isolated on selective media for pathogenic Neisseria as N.sicca 
and  N.mucosa  give  false  results.  The  enzymatic  identification  system 
uses  specific  biochemical  substrates  that,  after  hydrolysis  by  bacteria 
enzymes, yield a colored end product which is detected directly or after 
the  addition  of  diazo  dye.  Gonochek-II  includes  β-galactosidase,  γ -
glutamylamino  peptidase  and  prolyl-hydroxylprolyl  amino  peptidase 
enzymes.         
Genogen II test
This test uses protein I monoclonal antibodies that are conjugated 
with colloidal gold as the detection reagent on a filter paper.47 Change of 
22
the  filter  paper  colour  to  red  is  suggestive  of  N.  gonorrhoeae. 
Culture  confirmation probe test:  The acuprobe N.  gonorrhoeae culture 
confirmation test identifies the organism by detection of specific RNA 
sequences that are unique to gonococcus.47 This test is found to be 100% 
accurate in identifying N. gonorrhoeae.
DIRECT ANTIGEN DETECTION IN CLINICAL SPECIMENS       
These  tests  are  rapid,  highly  sensitive  and  specific  and  a  large 
number of specimens can be processed at one time and available for the 
direct detection of organism in urogenital specimens.          
Solid Phase Immonoassay 
ELISA is commercially available as "Gonozyme". It is useful as a 
rapid alternative to culture, especially in transport delays. It is useful in 
genital sites only.48         
Nucleic Acid Hybridization
All  nucleic  acid  detection  methods  can  be  carried  out  on  dead 
organisms  and  are  suitable  where  culture  is  impracticable  or 
inconvenient.  Proved  to  be  highly  sensitive  and specific.  Problems  of 
non-specific  inhibition  by  genital  secretions  have  shown   reduced 
sensitivity.         
Ribosomal RNA Probe 
Gen- Probe Pace 2 system (Gen-Probe Inc San Diego, CA, USA) 
uses  magnetic  bead  separation  stage  and  a  chemiluminescent  labeled 
DNA probe to  detect  gonococcal  rRNA. It  is  very  quick  but  requires 
expensive kits and equipment. In high prevalence population sensitivity is 
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between 94.2% and 100% with specificities between 99.8% and 99.9% 
for specimens from both sexes and including those from non-genital sites. 
Plasmid DNA probe
Probes made complementary to the 2.6 MDa cryptic plasmid and to 
the  4.4  MDa  penicillinase  conding  plasmid  of  gonococci  have  been 
tested.  Radioactively  labeled  probes  was  designed  for  reference 
laboratory for screening of populations on a different continent. Results 
were comparable with culture and permitted the detection of penicillinase 
production.
Polymerase / Ligase Chain Reaction Techniques 
Sensitive  and  specific  system,  uses  a  portion  of  the  2.6  MDa 
plasmid  that  is  also  presented  on  the  gonococcal  chromosome. 
Roche  Molecular  system has  extended their  Amplicor  PCR system to 
include a second generation multiplex test which simultaneously detects 
N.  gonorrhoeae  and Chlamydia  trachomatis.  Showed 100% sensitivity 
and 99% specificity in clinical samples.49
Nested PCR
Technique  is  used  to  demonstrate  gonococcal  DNA  in  sterile 
synovial fluids of patients with gonococcal arthritis.          
Ligase chain reaction technique detecting Opa and pilin genes was 
developed  by  Birkenmeyer  and  Armstrong.  Examining  genital, 
extragenital  swab and first  voided samples  from both sexes  found the 
overall performance superior to culture.50
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SEROLOGICAL TESTS         
Gonococcal antibodies such as pilin, P.I or P.II antibodies can be 
detected  by  complement  fixation  test,  latex  agglutination  test,  indirect 
immunofluorescence, radioimmunoassay, indirect haemagglutination test, 
ELISA and western blotting. The presence of cross- reactive antibodies to 
antigens of other Neisseria species or species of other bacterial genera 
and antibody persistence from past infections may be a limiting factors 
that alter the sensitivity and specificity of these tests. 
TREATMENT          
Effective treatment of gonorrhoeae is defined as the elimination of 
N. gonorrhoeae from all  anatomic sites.51 An ideal antimicrobial  agent 
forthe first line of treatment of gonorrhoeae should eradicate more than 
95% of the organisms in uncomplicated anogenital infection.         
Antimicrobial Options 
Before the advent of sulphonamides in 1935, gonorrhoea therapy 
involved  local  genital  irrigation  of  antiseptic  solutions  such  as  silver 
nitrate or potassium permanganate or passage of urethral sound. By 1944, 
treatment  failure  with  sulphonamides  occurred  in  about  one  third  of 
patients and this increased to about 90% by the end of 1940's.52
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Penicillins 
Introduced for treatment of gonorrhoea by Mahoney, Arnold and 
Harris in 1943. Single dose treatment  with penicillin was the standard 
regimen  followed.  Extended  spectrum  penicillins  such  as  ampicilin, 
amoxycillin,  ticarcillin,  piperacillin,  and  mezlocillin  also  showed 
significant  in  vitro  activity  against  non  β  lactamase  producing 
N.gonorrhoeae. 
Cephalosporins 
Third  generation  preparations  have  proved  highly  efficacious. 
ceftriaxone, cefotaxime, cefixime are the drugs which are recommended 
in the treatment of gonorrhoea.
Fluoroquinolones 
This group of drugs became popular in the mid 1980s. They are 
ciprofloxacin,  ofloxacin,  norfloxacin,  pefloxacin  and newer  quinolones 
like fleroxacin, endofloxacin, lomefloxcin and gemifloxacin. 
Other  antimicrobial  options  are  azithromycin,  spectinomycin, 
trospectinomycin, tetracyclines, gentamicin, kanamycin.
Problem of antimicrobial resistance      
Clinically  there  is  no  difference  between  infections  caused  by 
antibiotic  resistant  and antibiotic  sensitive  strains.  In  adequate  therapy 
results in extended period of infectiousness and an increase in the number 
of  sex  partners  who  become  infected.  The  sequelae  of  gonococcal 
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infection,  pelvic  inflammatory  disease  (PID),  gonococcal  ophthalmia, 
disseminated  gonococcal  infection  (DGI)  are  likely  to  increase  due  to 
inadequate therapy.53       
Resistant strains in the community also have an adverse impact on 
the costs of patient management-additional laboratory tests, added drug 
costs, extra clinic visits and more extensive intervention activities.      The 
pattern of antimicrobial resistance varies widely. It is highest in countries 
where  effective  therapy  is  either  unavailable  or  too  expensive  and 
facilities for diagnosis are inadequate, and often is coincident with a high 
prevalence of HIV infection.54 The treatment regimens should therefore 
be tailored to the prevalence of antimicrobial resistance in each country 
or region to prevent spread of resistant strains.      
From  epidemiological  point  any  method  of  treatment  which 
givesmore than 5% of treatment failure must be regarded as ineffective.
Factors Contributing to Emergence of Resistant Strains
1. Natural selection           
When  a  microbial  population  is  exposed  to  an  antibiotic,  more 
susceptible organisms will succumb, leaving behind only those resistant 
tothe  microbial  onslaught.  These  organisms  can  then  pass  on  their 
resistance  to  others  by  conjugation  or  transformation.  This  process  is 
exacerbated by the abuse,  overuse and misuse of antimicrobials  in the 
treatment  of  human illness  and in  animal  husbandry,  aquaculture,  and 
agriculture.
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2. Drug access and resistance
          Poverty and inadequate access to drugs contribute to be a major 
force  in  the  development  of  resistance.  Poor  quality,  counterfeit  or 
truncated  treatment  courses  leads  to  more  rapid  selection  of  resistant 
organisms.55
3. Misdiagnosis and resistance          
In  developing  countries  problems  like  prescribing  inadequate 
amount  of  antimicrobials  or  unnecessary  antibiotics  or  antibiotics  of 
wrong  choice  are  responsible  whereas  in  developed  countries  over 
prescribing antibiotics contribute to resistance.
4. Counterfeit drugs     
When  antibiotics  are  prescribed  at  lower  levels  than  treatment 
guidelines indicate, resistance can flourish. Counterfeit drugs may have 
weaker ingredient, wrong ingredient of no active ingredient.    
5. Dubious Pay-offs and High Priced Prescriptions         
Countries where health care providers earn only subsistence wages, 
unethical  pharmaceutical  companies  sometimes  pay  a  commission  for 
recommending more expensive broad spectrum antibiotics when cheaper 
narrow spectrum alternatives would suffice.
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6. Patient Pressure         
Prescribing  wrong  or  unnecessary  antibiotics  due  to  patient 
demand  for  antimicrobials  can  contribute  to  the  development  of 
resistance.
7. Lack of Education          
In many countries the majority of patients purchase antimicrobials 
and other drugs without visiting a health worker first. Many drug retailers 
advise  their  consumers  to  buy  non-essential  drugs  as  they  are  under-
educated and under-informed.
8. Resistance and Hospitals          
Some teaching hospitals sometimes unwittingly promote the type 
of irrational drug dispensing without proper investigations that contribute 
to resistance.
9. Globalization and Resistance          
International  travel  and  trade  can  contribute  to  development  of 
resistance.  Lack  of  political  will  by  some  governments  and  little 
enforcement  of  effective  guidelines  within  health  care  institutions  can 
contribute to resistance.
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10. Practice of Chemoprophylaxis          
Prophylactic  administration  of  antibiotics  immediately  or  soon 
after sexual exposure clearly reduces the risk of infection. This practice is 
likely to select and facilitate transmission of antibiotic resistant strains. A 
history of self-initiated antimicrobial  prophylaxis was found associated 
with infection with ciprofloxacin-resistant gonococci.56
11. Other factors          
Use of selective media  containing vancomycin  in  the laboratory 
diagnosis  of  gonorrhoea  is  associated  with  emergence  of  PPNG. 
Certain biologic characteristics of gonococcal infection short incubation 
period and ability to produce asymptomatic infections favour spread of 
resistant strains.
Mechanism of antibiotic Resistance in Neisseria gonorrhoeae        
Antibiotic  resistance  in  N.gonorrhoeae  can  be  controlled  by 
plasmid  (PPNG  or  TRNG)  or  chromosomal  DNA  (CMRNG).  The 
knowledge  about  genetic  control  of  antibiotic  resistance  can  help  in 
understanding the spread of clinically significant resistant strains.
Penicillin Resistance 
Chromosomal- mediated resistance
Gonococcal strains that require 2µg or more/ml of penicillin for 
inhibition  and  do  not  produce  β-lactamase  are  designed  as 
chromosomally mediated penicillin resistant N. gonorrhoeae (CMRNG).  
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This  type  of  resistance  is  as  a  result  of  the  additive  effect  of 
mutations  at  multiple  loci,  including  pen  A  (encodes  for  penicillin 
binding  protein  2),  mtr  (controls  antibiotic  susceptibility  by  an  efflux 
system which actively removes the antibiotic from the cell) and pen B 
(closely linked to porin protein of gonococcus) 57
Plasmid Mediated penicillin resistance  
This  type  of  resistance  is  attributed  to  the  production  of  
β  lactamase  via  single  step  acquisition  of  plasmids.  β  lactamase  or 
Penicillinase acts  on the  β  lactam ring of  the penicillin  molecule  and 
destroys its antibiotic activity by converting it into inactive penicillinoic 
acid.           
The biological characteristics of PPNG stains isolated from Asia 
and Africa are different.58  The Asian strains are proline dependent and 
carry the 4.4. MDa plasmid. There is an additional conjugate 24.5 MDa 
large plasmid associated with it. The presence of the associated conjugate 
plasmid in Asian strains is responsible for rapid spread of resistance to 
other gonococci.          
The African strains are arginine dependent and carry the 3.2 MDa 
plasmid,  which  is  not  associated  with  the  large  conjugative  plasmid, 
hence  dissemination  of  these  strains  occurs  more  slowly.  Both  the 
plasmids encode for the TEM-1 β  lactamase.
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Tetracycline-resistant N. gonorrhoeae (TRNG) 
TRNG are attributed either to multistep chromosomal mutations or 
the  acquisition  of  a  tetracycline  resistant  plasmid.  (TC1).  Gonococcal 
isolated  requiring  more  the  2µg/ml  of  tetracycline  for  inhibition  are 
defined as chromosomally mediated TRNG. Chromosomal loci mediating 
low level tetracycline resistance have been designated mtr, penB and tet 
of  which  two  loci  (mtr  and  penB)  are  also  involved  in  mediating 
penicillin resistance.59          
Plasmid mediated resistance is due to the acquisition of the tet M. 
determinant  by the conjugate plasmid (24.5 MDa) resulting in  a TC1 
plasmid  of  25.2  MDa.  Plasmid  mediated  TRNG  strains  are  likely  to 
spread more rapidly than PPNG strains because of the presence of tet M. 
plasmid in other flora found in the genital tract including G. vaginalis,  
U. urealyticum and M. hominis. 
Fluoroquinolone resistant N. gonorrhoeae (QRNG) 
The  national  Committee  for  Clinical  Laboratory  Standard 
(NCCLS)  in  USA  has  defined  strains  of  N.  gonorrhoeae  resistant  to 
fluoroquinolones if they have minimal inhibitory concentrations (MICs) 
of more than 1µg/ml for ciprofloxacin or more than 2µg/ml for ofloxacin.
Resistance  to  fluoroquinolones  involves  number  of  separate 
chromosomally mediated mechanisms manifesting as sequential increase 
in MIC. It results from mutations in the DNA gyrase genes of changes in 
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the  cell  wall  permeability.  Moderate  level  of  resistance  results  from 
aminoacid changes in gyr A whereas mutants with high level resistance 
have been found to have changes both in gyr A and the topoisomerase IV 
gene, par C.
Cephalosporin resistance 
Analysis  of  mutations  in  a  strain  with  reduced  susceptibility  to 
ceftriaxone minimum inhibitory concentration (MIC) = 0.5 microg/mL) 
showed  the  N.  gonorrhoeae  strain  contained  a  significantly  different 
sequence  of  the  penA  gene  from  that  of  the  ceftriaxone-susceptible 
strains.            
This strain also included a ponA mutation that is associated with 
high-level  resistance  to  penicillin,  mtrR  mutations  that  mediate 
overexpression of the MtrCDE efflux pump responsible for resistance to 
hydrophobic  agents  such  as  azithromycin,  and  penB  mutations  that 
reduce porin permeability to hydrophilic agents such as tetracycline.        
Moreover,  this  strain  contained  gyrA  and  parC  mutations  that 
confer high-level resistance to ciprofloxacin. These results indicate the 
emergence  of  a  N.  gonorrhoeae  strain  with  reduced  susceptibility  to 
ceftriaxone, which also showed a multidrug-resistant phenotype.60
Spectinomycin resistance 
Spectinomycin resistance results from chromosomal mutations in 
the 16S rRNA genes resulting in decreased binding of the drug to its 
ribosomal target. 61 High level resistance occurs in a single step.
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Azithromycin resistance
Azithromycin resistance is due to over expression of the mtrCDE-
encoded efflux pump mediated  by mutations  in  the mtrR gene,  which 
encodes  a  transcriptional repressor  that  modulates  expression  of  the 
mtrCDE operon.62 Those strains which did not have the mutation in the 
mtrR  promoter  region,  were found  to  have  a  C2611T  mutation 
(Escherichia coli numbering) in the peptidyltransferase loop in domain V 
of the 23S rRNA alleles.63
Susceptibility testing
 Susceptibility testing may be performed by disk diffusion,  agar 
dilution (full MIC or breakpoint) or by commercially available E-test. In 
disk diffusion,  a small  disk impregnated with a given concentration of 
antibiotic  is  placed  on  the  surface  of  an  agar  plate  inoculated  with  a 
bacterial suspension. After overnight incubation the size of the zone of 
inhibition indicates the susceptibility of the organism.          
In agar dilution the antibiotic to be tested is serially diluted, and 
each at several concentrations this when added to an appropriated volume 
of medium, will give required concentration. A standardized suspension 
of  each  strain  is  inoculated  onto  the  series  of  agar  plates  using  a 
multipoint  inoculator.  Appropriate  sensitive  and  resistant  control 
organisms  should  be  included  with  the  series  of  test  isolates.  After 
overnight incubation the lowest concentration of antibiotic which inhibits 
the growth is taken as the MIC.          
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The E-test is a novel method of determining the MIC. The E-test 
consists  of  a  thin,  plastic  strip,  the  lower  side  of  which  contains  a 
continuous  concentration  of  gradient  of  stabilized  and  dried  antibiotic 
while the upper side is marked with a MIC scale. The strip is placed on an 
agar plate inoculated with a suspension of the test  organism and after 
overnight inoculation the intersection between the value printed on the 
edge of the strip and the inhibition zone is the MIC.
Comparability of results
The data collected should be comparable between laboratories, and 
therefore it is necessary to have uniform methodology for isolation and 
susceptibility testing of N. gonorrhoeae.
Interpretation of the results
This depends on proper performance of the test. For example in 
disk diffusion method, the variables that influence the outcome include 
the depth, pH, cation content, supplements, and source of the agar; the 
age  and  turbidity  of  the  bacterial  inoculum;  the  way  in  which  the 
inoculum  is  spread  on  the  plate;  the  temperature,  atmosphere,  and 
duration of incubation, the method of reading results; the antimicrobial 
content of the disks, their age and storage conditions; and more. For these 
reasons, performance of the test must strictly adhere to the guidelines and 
the  performance  monitored  by  periodically  testing  the  quality  control 
strains (ATCC 49226) of known susceptibility.
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Surveillance programmes        
Several studies done worldwide provide data about the prevalence 
of  antibiotic  resistant  strains.  Regional  programmes  for  monitoring 
gonococcal susceptibility have been developed in industrialized countries 
such  as  the  USA  (Gonococcal  Isolate  surveillance  Project  GISP), 
Australia (Australian Gonococcal surveillance programme), SEAR GASP 
(South  East  Asia  Region-  Gonococcal  Antimicrobial  Surveillance 
Programme), Canada and the Netherlands.          
A  global  surveillance  network,  the  gonococcal  antimicrobial 
Surveillance  programme  (GASP)  coordinated  by  the  WHO,  has  been 
established with an  aim to create a series of networks of laboratories 
based  on  WHO  regions  that  will  monitor  gonococcal  antimicrobial 
susceptibility and disseminate information on trends in susceptibility and 
emergence of resistance.54      
GLOBAL SCENARIO
Chromosomal-mediated penicillin resistance 
First reported in USA from north California in 1983.64 Since then 
increasing number  of  CMRNG strains  have been reported  from USA. 
Australian surveillance programme detected CMRNG in 8.5% isolates in 
1995.                
Highest  percentage of  CMRNG strains has been reported in  the 
south-east Asian countries including Philippines, Thailand and Indonesia. 
In a study in Bangkok in 1995 CMRNG was exhibited by 36%  of strains. 
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In Japan in 2002 CMRNG is  present  in  12.6% of isolates.  In  arecent 
study from Bombay 3% of the isolated strains were CMRNG. 
Plasmid-mediated penicillin resistance
The first PPNG strain emerged in the far east and west Africa in 
1975.65  In USA in 1999 2.1% of the isolates  were PPNG strains.  The 
prevalence of PPNG is the highest in south East Asia and Sub-Saharan 
Africa.
In India PPNG was first reported by Vijayalakshmi et al from the 
Institute of Venereology, Madras in 1980. In a study conducted in 2001 in 
Chennai  from the Institute  of  Venereology showed 35.8% of  isolates 
were PPNG. 35.3% of isolates were found resistant to penicillin in New 
Delhi in 2003. A study from Bombay revealed 51.7% of isolates to be 
PPNG.                 
Report  from  China  in  1999  showed  32.65%  of  strains  showed 
penicillin resistance.67 In Rwanda 70.5% of strains were PPNG in 2000.  66 
In New Zealand 9% were penicillin resistant in 2002.Annual report of the 
Australian  Gonococcal  Surveillance  Programme,  2005  showed  29.5% 
penicillin resistant strains. 
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Fluoroquinolone resistance
Resistance  to  ciprofloxacin  and  ofloxacin  emerged  in  the  late 
1980s and early 1990s from patients in South East Asia In USA 16% of 
isolates were QRNG in 1994.  In 1994 21.8% and 10.4% strains were 
resistant to ciprofloxacin from Thailand and Hong Kong respectively. In 
Philippines 72.6% of isolates in 1996-97 were QRNG. In China 82.65% 
of  strains  were  QRNG in  1999.  In  New Zealand in  2002 6.8% were 
QRNG.  In Australia 30.6% QRNG isolates were found in 2005.          
In  India  15.2%  isolates  showed  resistance  to  ciprofloxacin  in 
Bombay in 1999. In Chennai 24.5% of strains were QRNG in 2001. In 
2003 67.3% of isolates were found to be QRNG in New Delhi.
Cephalosporin resistance
In 1999 13.27% of isolates were found resistant to ceftriaxone in 
China.67 Multidrug-resistant  Neisseria  gonorrhoeae  with  decreased 
susceptibility to cefixime isolated in Hawaii, 2001. 9.2% of isolates were 
resistant to cefixime in Japan in 2002. 17.5% of strains were resistant to 
ceftriaxone  in  Sverdlovsk  in  2003.68 Slightly  more  than  1%  showed 
resistance to ceftriaxone in Australia in 2005.          
In Chennai 3.7% of isolates were resistant to ceftriaxone in 2001.In 
2003 5.9% of the isolates were found less sensitive to ceftriaxone in New 
Delhi.
38
Spectinomycin resistance 
In  China  in  1999  8.16%  of  isolates  showed  spectinomycin 
resistance.  In  Trinidad  in  2001  9%  of  strains  exhibited  resistance  to 
spectinomycin.           
In Chennai 22.2% of isolates were resistant to spectinomycin in 
2001.
Azithromycin resistance
28.3%  of  isolates  from Manaus,  Brazil,  1998  showed  reduced 
susceptibility  to  Azithromycin.  .  9.8%  of  isolates  were  resistant  to 
Azithromycin  in  Cuba,  1995-1998.  Isolates from Nepal  in  2003, 19% 
exhibited reduced susceptibility.
ACO guidelines for the treatment of gonorrhoea:
Uncomplicated gonococcal infection
This includes anterior urethritis and proctitis in males; cervicitis, 
urethritis and proctitis in females and pharyngitis in both.
Recommended regimens
Azithromycin, 2g orally as a single dose *  or
cefixime, 400 mg orally as a single dose or     
ceftriaxone, 250 mg intramuscular (IM) as a single injection 
* Will treat both gonococcal and chlamydial infections.
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FOLLOW UP
Patient has to be followed on 3, 7, 14, 30th day. Direct gram stained 
smears  of  centrifuged  urine  deposit  and  discharge  done.  If  smear  is 
positive and the patient had complaints, culture was repeated and treated 
as failure. In females endocervical swab taken and culture done.
Epidemiological treatment
All  sex  partners  exposed  within  2  weeks  prior  to  the  onset  of 
symptoms in patients with gonorrhoea has to be treated. For patients with 
asymptomatic gonococcal infection, however extending contact tracing to 
1 month may be useful.
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AIMS AND OBJECTIVES
1. To identify the gonococcal infection in patients attending the STD 
clinic.
2.  To study the antimicrobial susceptibility of gonococcus.
3.  To study the prevalence of Penicillinase producing N. gonorrhoeae.
4. To study the associated sexually transmitted infections.
5.  To  modify  the  disease  intervention  activities  and  therapy 
recommendations accordingly.
Purpose of the study
The knowledge of the prevalence of antibiotic  resistant strains is 
essential for instituting disease control and preventive  measures. In India 
we do not have enough data about the prevalence of  antibiotic resistant 
strains. Efforts are being made to widen the SEAR  GASP (South East 
Asia Region Gonococcal Antimicrobial surveillance programme) network 
in India. Treatment recommendations has to be changed depending upon 
the surveillance data.
WHO  no  longer  recommends  a  single,  first  line  treatment  for 
gonorrhoea.  Instead  each nation must  make  decisions  according to  its 
own resistance situation as resistance levels vary from one nation to the 
next indeed from clinic to clinic.55
41
MATERIALS AND METHODS
Study design
     Prospective observational study.
Sample
     43 patients with gram stained smear or culture positive  for 
gonococcus   who  attended  the  Institute  of  Venereology,  Government 
General Hospital, Chennai from February 2005 to September 2006.
Methodology
Routine history and clinical examination was done for all patients. 
Appropriate specimens were collected according to the duration of illness 
and site of gonococcal  infection. Data regarding the age, sex, risk factors 
associated with clinical illness and transmission factors were obtained. 
All  patients  were  treated  as  per  NACO  guidelines  with  either 
ceftriaxone or azithromycin. Follow up was done on 3, 7, 14 and 30 days. 
Screening  for other sexually transmitted diseases was done and treated 
according to the Institute guidelines
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SPECIMEN COLLECTION 
In Males 
1. Urethra : Patient were instructed not to urinate for 1 to 2 hours  before 
specimen collection. Specimens were collected by wearing sterile gloves. 
In cases of urethral discharge (figure 1) the prepuce was retracted, area 
around the urethral  meatus was cleaned with sterile normal  saline and 
urethral  discharge  was  collected  in  two sterile  platinum loops.  Direct 
plating  was  done  at  bed  side.  The  second  loop  was  used  for  gram 
staining.
If  there  is  no  discharge  or  only  minimal  discharge  present,  the 
urethra  was milked towards the orifice to express the discharge and then 
the  specimen was collected.  Even on milking there was no discharge 
then a sterile charcoal treated swab was inserted 2-3 cms into the urethra 
and gently rotated for 5-10 seconds to scrape the mucosa. A wet mount 
examination was also made from the discharge to rule out trichomoniasis 
and candidiasis.
2. Urine : 5-10 ml of first voided urine was collected in a sterile test tube 
and centrifuged deposit was used for direct plating and gram staining.
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In females
1.  Endocervix: A sterile  Cusco's  self  retaining vaginal  speculum was 
inserted  into  the  vagina  (lubricant  not  used)  and  the  endocervix  was 
visualized (figure 2). Cervix was cleaned with clean sterile cotton wool 
swab to remove cervical mucosal plug. Specimen was collected with two 
swabs.  The  first  sterile  charcoal  treated  swab  was  inserted  into  the 
endocervical canal for 2 cms and rotated for 5-10 seconds to collect the 
specimen.
Specimen was inoculated into the culture medium. Second sterile 
swab was used for gram staining. A wet mount preparation was done by 
mixing one drop of discharge from the posterior fornix of the vagina and 
one drop of normal saline over a clean glass slide and placing a coverslip 
over it.
MICROSCOPY
Wet Mount Examination: 
The  slide  was examined first  under  10x magnification  and then 
under  40x  magnification,  to  look  for  trichomonads  and  polymorphs. 
(figure 3)
Gram stain
A thin smear was prepared on a clean glass slide by rolling the 
swab  on the  slide.  After  air  drying and heat  fixing the  smear,  it  was 
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stained with gram stain. It was examined under 100x magnification, to 
look for the presence of epithelial cells,  polymorphonuclear leucocytes 
and  the  location  of  gram negative  diplococci  whether  intracellular  or 
extra cellular( figure 4,5).
Culture
The specimen collected for the culture is immediately inoculated 
on the selective medium (Modified Thayer Martin Medium with VCNT) 
and non selective chocolate agar. The culture plate is incubated at 35-36o 
C in moist humid air containing 5-10% Co2 in a candle jar, humidity was 
obtained by using sterile moist  cotton ball  (figure 6).  The plates  were 
examined after 24 hrs and if there were no growth the plates were further 
incubated and read after 48 hours. Colonies which showed gram negative 
diplococci in Gram stain, oxidase positive  were identified presumptively 
as N. gonorrhoeae and sub cultured on to  chocolate agar for further tests 
like sugar degradation test, β-lactamase test and antibiotic sensitivity.
Colony characters
Thayer- martin agar: Small pinpoint colonies circular glistening with 
entire  edge raised,  convex,  grayish,  translucent/  opaque colonies  were 
seen (figure 7,8).
Chocolate agar: Medium sized colonies, convex, greyish, translucent / 
opaque colonies were seen.
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Identification of N. gonorrhoeae from culture
1. Gram staining 
The smear prepared from colonies grown, is stained with grams 
stain to look for gram negative diplococci.
2. Oxidase test
A drop of freshly prepared aqueous solution of 1% tetra methyl 
paraphenylene  diamine  dihydrochloride  is  added  on  a  colony  and 
immediate development of purple colour (within 5-10 seconds) indicates 
a positive test.(figure10)
3. Sugar degradation test
N. gonorrhoeae utilizes glucose only but not maltose or lactose or 
sucrose. The tube containing glucose changes from red to yellow. The 
control tube remains red.(figure11).
β  Lactamase test
   Rapid tube Iodometric test for detection of penicillinase producing 
Neisseria gonorrhoeae (PPNG) was used. Several colonies from 24 hours 
pure culture were taken in a loop and a heavy turbid suspension is made 
in 0.1 ml of penicillin solution (Penicillin G powder in phosphate buffer) 
in a small test tube. 2 drops of starch solution is added to the suspension 
of  bacteria and penicillin and mixed. 1 drop of iodine reagent is added 
with  a  pasteur  pipette.  A control  tube  without  the  organism was also 
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included. The solution will immediately turn blue because of reaction of 
the iodine and starch. Rapid decolourisation indicates the production of 
β  lactamase. (figure12).
ANTIBIOTIC SENSITIVITY TESTING
The antibiotic sensitivity testing in N. gonorrhoeae was done by 
Kirby-Bauer disk diffusion method. Sensitivity for Penicillin G(10 units), 
Ciprofloxacin  (5mcg),  Ceftriaxone  (30mcg),  Cefixime  (5mcg), 
Spectinomycin (100mcg) and Azithromycin (15mcg) were tested. 
2 ml of gonococcus suspension (10 colonies from a pure subculture 
plate mixed with 5 ml of phosphate buffered saline) was pipetted out on a 
dry  sterile  culture  plate  (GC  agar  with  haemoglobin  and  isovitalex 
supplements). The Plate was tilted in all directions so that the whole plate 
surface  becomes  wet.  The  remaining  fluid  is  removed  with  a  pasteur 
pipette and the plate was dried in the incubator in inverted position at 
37oC for 30 minutes. The antibiotic disks were placed on the agar plate 
using sterile forceps maintaining a gap of 2.5 cms between two disks. The 
plate was incubated in a candle extinction jar at 37oC in a incubator for 
18-24 hours. If the organism is sensitive there is a clear zone around the 
disk (figure13,14). 
The  diameter  of  the  clear  zone  is  measured  using  a  ruler  and 
interpreted accordingly. The zone size for interpretation are given in the 
appendix.
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RESULTS
         Specimens from 43 patients (40 male, 3 females) were collected. 
The number  of patients  diagnosed by smear  and culture are given in  
table 1. 91% of patients were in the age group of 20-40 years (chart 1). 
45% of  males  and 100% of females  were married (chart  2).  90% of 
males and 66%  of females were literate (chart 3). 90% of males were 
employed (chart 4).  85% of males had heterosexual orientation, 12.5% of 
males  had  bisexual  orientation  and  2.5%  had  homosexual  orientation 
(chart  5).  52.5% of  males   had  last  sexual  exposure  with  CSWs and 
32.5% of males with known  contacts (chart 6). All male patients had 
urethral discharge. 42.5% of males had dysuria. 33% of females had no 
symptoms (chart 7).  
Antibiotic  sensitivity  tests  were  carried  out  on  40  isolates  of 
Neisseria   gonorrhoeae obtained in pure culture.  70% of isolates were 
resistant  to penicillin and 30% were less  sensitive to it.  52.5% of the 
isolates were  PPNG. 57.5% of isolates were resistant to ciprofloxacin 
and 42.5% were  less sensitive to it. 7.5% were resistant to ceftriaxone, 
12.5%  were  resistant  to  cefixime  and  15%  were  resistant  to 
spectinomycin. All the isolates were  sensitive to azithromycin (Table 2).
All the 43 patients were treated according to NACO guidelines,  
20  patients  with  Injection  Ceftriaxone  250  mg  IM  single  dose  and  
23  patients  with  Tab.  Azithromycin  2  grams  single  dose  and  were 
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followed up. Out of 43 patients 30 turned for follow up and all showed 
signs  of  cure.  No  treatment  failures  were  noticed  with  ceftriaxone  or 
azithromycin.
Associated STDs
Three  male  patients  had  HIV  (6.9%).  Three  male  patients  had 
Syphilis  and  one  had  Genital  Wart.  One  female  patient  had 
Trichomoniasis. (Table 3)
Table-1: Smear and culture results
                    Positive                    Negative
     Male     Female       Male     Female
Smear      40         2           0           1
Culture      37         3           3           0
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Table-2: Anti Microbial Sensitivity of Gonococcus
Name of the 
drug
Sensitive Moderately sensitive Resistant
No % No % No %
Penicillin 0 0 12 30 28 70
Ciprofloxacin 0 0 17 42.5 23 57.5
Ceftriaxone 37 92.5 - - 3 7.5
Cefixime 35 87.5 - - 5 12.5
Spectinomyci
n
34 85 0 0 6 15
Azithromycin 40 100 0 0 0 0
Table-3: Associated STDs
Male 
(No. of Patients)
Female 
(No. of Patients)
Syphilis 3 0
HIV 3 0
Genital Warts 1 0
Trichomoniasis 0 1
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DISCUSSION
A total 43 patients with gonococcal infection were studied in detail. 
The  analysis  of  age  incidence  in  the  present  study  showed  67.4% of 
patients  were in the age group of 20-30 yrs which is the sexually active 
group where  other STD are also common. The next predominant  age 
group was 31-40 yrs. This analysis correlates with the study by Mehta 
Swami D et al.69
         In our study 47.5% of the males were unmarried. Bjekic M.Vlajinac 
et al70 showed that both sexes gonorrhoea infection was  commonest in 
populations who has never married and the present study is similar.
         According to our study 52.5% of males had contact with the high 
risk  group CSW who form the core group in the transmission of STD. 
Jaiswal  AK et al71 reported that the main source of infection (74.5%) was 
female  commercial sex workers. In our study also CSW played a major 
role in the  transmission of gonorrhoea. 
         In our study 2.5% of males had homosexual orientation and 12.5% 
of  males  had  bisexual  orientation.  Dafferty  WF72 reported  8.4% 
gonorrhoea in  homosexuals which is higher than our present study. A 
Mcmillan et al73   reported that unprotected receptive anal sex was most 
risky  factor  favoring  transmission  of  gonorrhoea  and  HIV.  Hence 
anoreceptive  contact  tracing  is  an  essential  criteria  to  prevent 
transmission.
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         As per the present study 100% of males presented with urethral  
discharge and 33% of females  were asymptomatic  this correlates  with 
Peter  Leone74 who  reported  90%  of  newly  acquired  infection  were 
symptomatic  and  50%  of  women  with  endocervical  infection  were 
asymptomatic.  Symptomatic  males  report  earlier  for  treatment,  but 
females who are  asymptomatic do not take treatment and come with later 
complications like  pelvic inflammatory diseases and infertility.
         According to our study Gram stained smear were positive in 100% 
of   males  and  66%  of  females.  This  correlates  with  the  study  by  
Sherrard.  J  and   Barlow-D75 which  showed  urethral  gonorrhoea  was 
diagnosed by  microscopy in 94.4% of gonorrhoea in men. Gram staining 
of  genital   secretions  still  remains  the  only  widely  accepted  routine 
procedure for  making an 'on the spot' diagnosis of gonococcal infection.
For interpretation of results of disk diffusion tests, three categories 
of  results are proposed.53
1. A susceptible result implies a < 5% likelihood of treatment failure.
2. An intermediate result indicates predictable failure rates of 5% - 
15%   if  the  patient  is  treated  with  the  tested  antibiotic  in  the 
standard   dosage.
3. A resistant result is associated with clinical treatment failure rates 
of > 15%.
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Treatment failure may result from variety of causes, and patients 
may  experience failure of therapy even when infected with isolates that 
manifest in vitro susceptibility. Test result must be used as an adjunct to 
not in place of clinical evaluation.53
 In this study 70% of the isolates were resistant to penicillin. In 
1987, 74% of isolates were found resistant to penicillin from India.76 In a 
recent  study  35.3% of  isolates  were  found  resistant  to  penicillin  in   
New Delhi in 2003.9 
52.5% of isolates in this study were PPNG. In a study conducted in 
the Institute of Venereology in 2001 the prevalence of PPNG was 35.8%. 
The prevalence of PPNG in different studies varies from 8-70% in South 
and  South  East-Asia.(  8%  in  New  Delhi,  15%  in  Dhaka,  17.8%  in 
Thailand, 51.7% in Bombay, 52% in Indonesia and 70.7% in Philippines) 
Ciprofloxacin resistance was found in 57.5% of isolates. In a study 
in  New  Delhi  in  2003,  67.3%  of  the  isolates  were  resistant  to 
ciprofloxacin. This is comparable to our results.  
Not  even a  single  isolate  was  sensitive  to  neither  penicillin  nor 
ciprofloxacin in our study. Penicillin is not recommended for treatment 
either by WHO or by CDC. Continuing treatment with penicillin would 
contribute to treatment failures and prolonged period of infectivity and in 
turn  spread  of  resistant  strains  in  the  community.  Resistance  to 
ciprofloxacin showed by all isolates was disturbing.          
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Resistance to ceftriaxone and cefixime were present in 7.5% and 
12.5%  of  the  isolates  respectively.  This  is  a  matter  of  concern.  The 
previous  study  from this  Institute  in  2001  showed 3.7% resistance  to 
ceftriaxone.  In 2003 5.9% of the isolates  were found less  sensitive to 
ceftriaxone in New Delhi. Out of the 3 isolates taken from patients who 
showed resistance to ceftriaxone 2 were treated with Inj. ceftriaxone 250 
mg im single dose. But these 2 patients responded well to treatment and 
there was no treatment failure. (In vitro resistance).         
Resistance to spectinomycin which is least used was 15% in our 
study.        
All the 40 isolates were sensitive to azithromycin in our study. This 
looks promising since NACO recommends azithromycin as one of the 
drugs in the treatment of gonorrhoea. It also has the added advantage of 
covering Chlamydial infection.                
Since no control strains (reference strains) were used in the study, 
all  results  must  be  verified  by  disk-diffusion  or  preferable  by  agar 
dilution  method  which  also  incorporates  reference  strains. 
Quality  control  is  necessary  for  comparing  results  from  different 
laboratories done under different conditions.         
Going  by  the  results  of  the  study  azithromycin  and 
ceftriaxoneappears  to  offer  hope.  Further  studies  using  agar  dilution 
method are to be done before treatment recommendations are to be made. 
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Among the associated infections in this study, HIV infections were 6.9% 
of the total gonococcal cases. Co infection with Syphilis was present in 3 
cases. All the three were latent Syphilis. One patient had Genital Wart. 
Out of 3 female patients one 33% had Trichomonas vaginalis infection. 
Vazquez-F et al77 reported Trichomonas vaginalis isolated in gonorrhoea 
was 40.4% which correlates with our present study.          
Surveillance for antibiotic resistant strains is essential for providing 
data for disease intervention.          
Treatment  of  male  patients  diagnosed by gram-stained smear  at 
Primary care level should be done according to prevailing guidelines. At 
tertiary care levels it is better to treat patients based on sensitivity reports 
at least for cases with treatment failures.           
Surveillance  work  should  include  both  Government  and  private 
sectors. Prompt analysis and review of the data should be done so that 
appropriate adjustments can be made in disease intervention activities and 
therapy  recommendations.  Appropriate  funds  should  be  allotted  under 
STD  control  programmes  for  establishing  laboratory  facilities  for 
surveillance.  Training  laboratory  personnel  and  quality  control 
procedures  should  be  incorporated  in  surveillance  programmes. 
Gonococcal  Antimicrobial  Surveillance Programme (GASP) started by 
the WHO in 1990 with an aim to establish a network of laboratories for 
surveillance based on WHO regions. Adoption of uniform methodology 
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by  training  programmes  and  quality  control  programmes  are  a 
prerequisite for involvement in GASP.           
In 1987, the Centers for Disease Control and Prevention (CDC) in 
collaboration  with  other  organizations  implemented  the  Gonococcal 
Isolate Surveillance Project (GISP) to monitor antimicrobial resistance in 
the United States.           
WHO has proposed wisely and widely points of action for over-
coming antimicrobial resistance. These include adopting WHOs policies 
and strategies,  educating  health  workers  and the public  on the  use  of 
medicines,  measures  to  contain  resistance  in  hospitals,  increasing 
research  for  new drugs  and  increasing  availability  of  essential  drugs. 
WHO recommends that surveillance data be analyzed and distributed to 
health  care  workers  in  order  to  assist  them  in  prescribing  drugs 
appropriately.           
Educating the public and health care workers on the wiser use of 
antimicrobial  drugs  is  imperative  to  halt  the  spread  of  resistance. 
Governments, Professional societies and teaching institutions must keep 
health care priorities upto date by supplying necessary information on the 
selection  of  correct  drugs,  dosages  and  optimum  treatment  durations 
necessary for effective for patient management.           
Educating consumers and the community on the judicious use of 
antimicrobials is also critical in tackling the problem of drug resistance. 
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Patients need to recognize the value of antimicrobials, how to use them 
and how not to use them, the importance of taking them as required, and 
avoiding them when unnecessary.           
WHO  encourage  hospitals  to  form  drugs  and  therapeutics 
committees aimed at establishing treatment guidelines. These encourage 
drug-use  monitoring  and  infection  control  thereby  preventing  the 
transmission and spread of resistant organisms.          
Encouraging the research community to develop new compounds 
is essential as once-effective treatment become inefficient in the face of 
ever  evolving  resistant  microbes.  Research  into  dosage  regimens 
calculated to minimize the likelihood of selecting for resistance is also 
important.
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CONCLUSION
1. The results of the study indicate that multidrug 
resistant  Neisseria  gonorrhoeae is  prevalent  in 
this region.
2. The value of Penicillin and Ciprofloxacin as drugs 
for the treatment of Gonorrhoea is doubtful as 
all  the  strains  were  either  less  sensitive  or 
resistant to these drugs.
3. Azithromycin  looks  promising  with  no  drug 
resistance.  
4 Associated  STDs  has  to  be  investigated  to 
prevent  the  transmission  of  HIV  and  further 
complications.  
5. Need  for  establishing  a  national  surveillance 
programme  for  antibiotic  resistance  becomes 
clear.
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